{"pmid":32241193,"title":"COVID-19: Challenges and opportunities for dermatology response.","text":["COVID-19: Challenges and opportunities for dermatology response.","As the world faces an unprecedented challenge in the novel coronavirus disease-2019 (COVID-19) pandemic, which as of 21 March 2020 has had 287,239 confirmed cases and 11,921 number of deaths worldwide, its consequences have reached all facets of medicine, including dermatology.(1) It remains a rapidly evolving scenario with guidance being updated regularly to reflect new information. Whilst it presents unique challenges to dermatology, it also presents an opportunity to help drive the development of new infrastructure to adapt and improve dermatology practice.","J Dermatolog Treat","Chawla, S","32241193"],"abstract":["As the world faces an unprecedented challenge in the novel coronavirus disease-2019 (COVID-19) pandemic, which as of 21 March 2020 has had 287,239 confirmed cases and 11,921 number of deaths worldwide, its consequences have reached all facets of medicine, including dermatology.(1) It remains a rapidly evolving scenario with guidance being updated regularly to reflect new information. Whilst it presents unique challenges to dermatology, it also presents an opportunity to help drive the development of new infrastructure to adapt and improve dermatology practice."],"journal":"J Dermatolog Treat","authors":["Chawla, S"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241193","week":"202014|Mar 30 - Apr 05","doi":"10.1080/09546634.2020.1751040","keywords":["COVID-19","outpatient","teledermatology"],"source":"PubMed","weight":0,"_version_":1663079112881733632,"score":7.6048946,"similar":[{"pmid":32237998,"title":"An Assessment of United States Dermatology Practices during the COVID-19 Outbreak.","text":["An Assessment of United States Dermatology Practices during the COVID-19 Outbreak.","Objectives: The COVID-19 outbreak is a serious threat to public health and social distancing on the part of individuals can help contain the epidemic. It is unknown if dermatologists are assisting with the public health officials' recommendations for social distancing by closing their practice or limiting their practice to the treatment of emergency conditions. This study examines the activity level of dermatology practices during the United States COVID-19 outbreak.Methods: We performed scripted phone calls to 60 dermatology practices in six different counties in the United Stated during the COVID-19 outbreak. We assessed if practices are open and if they are serving patients with urgent and non-urgent conditions.Results: Of the 60 dermatologists selected for the study, 55 were successfully contacted (92% contact rate). Of these practices, 29 (53%) were open, 17 (31%) were only seeing urgent patients and 9 (16%) were closed. New York, New York had 2 (20%) open offices which was the lowest proportion of any county (p=.04). Counties with higher prevalence had fewer open offices (p<.01, R(2)=.7).Conclusions: Many practices have restricted their level of operation especially in higher areas of COVID-19 prevalence, likely to help facilitate social distancing.","J Dermatolog Treat","Muddasani, Suraj","Housholder, Anne","Fleischer, Alan B Jr","32237998"],"abstract":["Objectives: The COVID-19 outbreak is a serious threat to public health and social distancing on the part of individuals can help contain the epidemic. It is unknown if dermatologists are assisting with the public health officials' recommendations for social distancing by closing their practice or limiting their practice to the treatment of emergency conditions. This study examines the activity level of dermatology practices during the United States COVID-19 outbreak.Methods: We performed scripted phone calls to 60 dermatology practices in six different counties in the United Stated during the COVID-19 outbreak. We assessed if practices are open and if they are serving patients with urgent and non-urgent conditions.Results: Of the 60 dermatologists selected for the study, 55 were successfully contacted (92% contact rate). Of these practices, 29 (53%) were open, 17 (31%) were only seeing urgent patients and 9 (16%) were closed. New York, New York had 2 (20%) open offices which was the lowest proportion of any county (p=.04). Counties with higher prevalence had fewer open offices (p<.01, R(2)=.7).Conclusions: Many practices have restricted their level of operation especially in higher areas of COVID-19 prevalence, likely to help facilitate social distancing."],"journal":"J Dermatolog Treat","authors":["Muddasani, Suraj","Housholder, Anne","Fleischer, Alan B Jr"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32237998","week":"202014|Mar 30 - Apr 05","doi":"10.1080/09546634.2020.1750556","keywords":["epidemic","pandemic","public health","spread"],"source":"PubMed","locations":["United Stated","United States","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1662996001852489728,"score":179.66704},{"pmid":32243612,"title":"WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","text":["WhatsApp messenger as a teledermatology tool during coronavirus disease (COVID-19): From Bedside to Phone-side.","The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19.","Clin Exp Dermatol","Deepak, J","Subuhi, K","Ishmeet, K","32243612"],"abstract":["The current coronavirus disease (COVID-19) has forced the shutdown of many non-essential services in most of the high-risk countries. Most of the consultations (except emergencies) in dermatology are deferred as a precautionary measure to prevent the spread of COVID-19."],"journal":"Clin Exp Dermatol","authors":["Deepak, J","Subuhi, K","Ishmeet, K"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243612","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ced.14227","keywords":["COVID-19","coronavirus","social distancing","teledermatology","telemedicine","whatsapp"],"source":"PubMed","locations":["Bedside"],"topics":["Prevention"],"weight":1,"_version_":1663079112821964800,"score":175.06636},{"pmid":32141058,"title":"Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.","text":["Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department.","As of Feb 15, 2020, the novel coronavirus (2019-nCoV) has rapidly spread throughout China and across the world with more than 60,000 laboratory-confirmed cases. Due to the current lack of specific treatment and the risk of transmission during the viral incubation period, infection prevention and control of 2019-nCoV are both urgent and critical to global health. In this article, we aim to highlight the necessity of implementing protective measures, and recommend how to set proper emergency management plans for preventing and controlling nosocomial infection of 2019-nCoV in dermatology departments.","Br J Dermatol","Tao, J","Song, Z","Yang, L","Huang, C","Feng, A","Man, X","32141058"],"abstract":["As of Feb 15, 2020, the novel coronavirus (2019-nCoV) has rapidly spread throughout China and across the world with more than 60,000 laboratory-confirmed cases. Due to the current lack of specific treatment and the risk of transmission during the viral incubation period, infection prevention and control of 2019-nCoV are both urgent and critical to global health. In this article, we aim to highlight the necessity of implementing protective measures, and recommend how to set proper emergency management plans for preventing and controlling nosocomial infection of 2019-nCoV in dermatology departments."],"journal":"Br J Dermatol","authors":["Tao, J","Song, Z","Yang, L","Huang, C","Feng, A","Man, X"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141058","week":"202010|Mar 02 - Mar 08","doi":"10.1111/bjd.19011","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662334543958376448,"score":152.74036},{"pmid":32219857,"title":"Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.","text":["Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.","Coronavirus disease 2019 (COVID-19) is the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as named by the International Committee on Taxonomy of Viruses (ICTV). There is very limited evidence base to formulate specific advice for dermatology patients on immunomodulators with regards to COVID-19. The following is based on expert opinion, taking into account known risks of influenza (a negative sense single-stranded RNA virus) and other, positive-sense single-stranded, RNA virus infections (such as SARS, MERS, and the common cold). An Australia/New Zealand consensus document is in development.","Australas J Dermatol","Rademaker, Mariu","Baker, Christopher","Foley, Peter","Sullivan, John","Wang, Charlie","32219857"],"abstract":["Coronavirus disease 2019 (COVID-19) is the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as named by the International Committee on Taxonomy of Viruses (ICTV). There is very limited evidence base to formulate specific advice for dermatology patients on immunomodulators with regards to COVID-19. The following is based on expert opinion, taking into account known risks of influenza (a negative sense single-stranded RNA virus) and other, positive-sense single-stranded, RNA virus infections (such as SARS, MERS, and the common cold). An Australia/New Zealand consensus document is in development."],"journal":"Australas J Dermatol","authors":["Rademaker, Mariu","Baker, Christopher","Foley, Peter","Sullivan, John","Wang, Charlie"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219857","week":"202013|Mar 23 - Mar 29","doi":"10.1111/ajd.13295","source":"PubMed","locations":["Australia","New Zealand"],"countries":["Australia","New Zealand"],"countries_codes":["AUS|Australia","NZL|New Zealand"],"topics":["Treatment"],"weight":1,"_version_":1662540582057148416,"score":146.05931},{"pmid":32238504,"title":"Neurologists and Covid-19: A note on courage in a time of uncertainty.","text":["Neurologists and Covid-19: A note on courage in a time of uncertainty.","Neurologists are used to uncertainty - diagnoses are frequently challenging, too often there are limited treatment options, and unpredictable prognoses are our bread and butter. When colleagues struggle to communicate bad news, they regularly turn to us. We practice staying steady and calm amidst our patients' fears, confusion, suffering, and anxiety. We listen, perform detailed exams, and do our best to provide helpful insights. This emphasis on listening and thoughtful problem solving is the core of our art and should be front and center as we partner with colleagues to face an unprecedented set of challenges related to the Covid-19 pandemic.","Neurology","Shellhaas, Renee A","32238504"],"abstract":["Neurologists are used to uncertainty - diagnoses are frequently challenging, too often there are limited treatment options, and unpredictable prognoses are our bread and butter. When colleagues struggle to communicate bad news, they regularly turn to us. We practice staying steady and calm amidst our patients' fears, confusion, suffering, and anxiety. We listen, perform detailed exams, and do our best to provide helpful insights. This emphasis on listening and thoughtful problem solving is the core of our art and should be front and center as we partner with colleagues to face an unprecedented set of challenges related to the Covid-19 pandemic."],"journal":"Neurology","authors":["Shellhaas, Renee A"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238504","week":"202014|Mar 30 - Apr 05","doi":"10.1212/WNL.0000000000009496","source":"PubMed","weight":0,"_version_":1662996001881849856,"score":124.5922}]}